Ac-S-D-K-P
CAS: 120081-14-3
Ref. 3D-FA73635
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
- 1-(N2-(N-(N-Acetyl-L-seryl)-L-a-aspartyl)-L-lysyl)-L-proline
- 120081-14-3
- N-Acetyl-L-seryl-L-alpha-aspartyl-L-lysyl-L-proline
Ac-S-D-K-P is a novel compound that is being investigated for its potential use as an anticancer agent. Ac-S-D-K-P has been shown to inhibit the polymerase chain reaction (PCR) in vitro, and can potentially be used for the treatment of cancer. The mechanism of action of Ac-S-D-K-P is not known; however, it may work by inhibiting the growth factor β1 or toll like receptor. Acetylation, deamination, and phosphorylation are three biochemical properties that have been studied in vitro with Ac-S-D-K-P. The compound has also been tested in vivo in rats and mice with bowel disease. These studies demonstrated that Ac-S-D-K is safe for long term use at doses up to 100mg/kg body weight, which means it could potentially be used for the treatment of cancer without toxicity to healthy tissues.
